Award
NIH Reporter #3R37CA260223-06S1
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell Production
Recipient
National Cancer Institute (NCI), part of the NIH, United States
Award Amount
$88,799.00
Ceiling
$88,799.00
Awarded
March 25, 2026
Identifier
3R37CA260223-06S1
Award for developing biomaterial scaffolds to improve CAR-T cell production, funded by NIH/NCI with $88,799 for fiscal year 2026.
Description
This project involves developing biomaterial scaffolds for the ex vivo and in situ production of CAR-T cells, aiming to reduce manufacturing time, improve efficacy, and enable in vivo generation of CAR-T cells. The award is funded by the NIH/NCI with a total amount of $88,799 for fiscal year 2026. The project is part of the PA-20-185 funding opportunity and is managed by the Biomaterials and Biointerfaces Study Section (BMBI).